Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis.
Lee DG, Kim JE, Lee WS, Kim MB, Huh CH, Lee YW, Choi GS, Lee JB, Yu DS, Shin MK, Roh MR, Ahn HH, Kim WS, Lee JH, Park KY, Park J, Lee WJ, Park MY, Kang H. Lee DG, et al. Among authors: shin mk. Aesthetic Plast Surg. 2022 Jun;46(3):1400-1406. doi: 10.1007/s00266-021-02715-4. Epub 2022 Feb 7. Aesthetic Plast Surg. 2022. PMID: 35132458 Clinical Trial.
Efficacy and safety of guselkumab compared with placebo and adalimumab in Korean patients with moderate-to-severe psoriasis: post-hoc analysis from the phase III, double-blind, placebo- and active-comparator-controlled VOYAGE 1/2 trials.
Youn SW, Yu DY, Kim TY, Kim BS, Lee SC, Lee JH, Choe YB, Lee JH, Choi JH, Roh JY, Jo SJ, Lee ES, Shin MK, Lee MG, Jiang J, Lee Y. Youn SW, et al. Among authors: shin mk. J Dermatolog Treat. 2022 Feb;33(1):535-541. doi: 10.1080/09546634.2020.1770174. Epub 2020 May 27. J Dermatolog Treat. 2022. PMID: 32419536 Clinical Trial.
Clinical outcomes in adult patients with plaque psoriasis treated with ustekinumab under real-world practice in Korea: A prospective, observational, multi-center, postmarketing surveillance study.
Youn SW, Yu DY, Kim BS, Kim Y, Kim KJ, Choi JH, Son SW, Lee ES, Ro YS, Park YL, Lee Y, Lee JH, Park HJ, Kim TY, Lee MG, Shin MK, Choi GS, Kim DH, Jo SJ, Lee SC; Stelara PMS investigators. Youn SW, et al. Among authors: shin mk. J Dermatol. 2021 Jun;48(6):778-785. doi: 10.1111/1346-8138.15670. Epub 2021 Feb 2. J Dermatol. 2021. PMID: 33528054
2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity.
Kim JE, Shin MK, Park GH, Lee UH, Lee JH, Han TY, Koh HC, Jang YH, Kim HO, Na CH, Lew BL, Ahn JY, Park CO, Seo YJ, Lee YW, Sohn SW, Park YL. Kim JE, et al. Among authors: shin mk. Ann Dermatol. 2019 Dec;31(6):654-661. doi: 10.5021/ad.2019.31.6.654. Epub 2019 Oct 31. Ann Dermatol. 2019. PMID: 33911665 Free PMC article.
Consensus Update for Systemic Treatment of Atopic Dermatitis.
Lee JH, Kim JE, Park GH, Bae JM, Byun JY, Shin MK, Han TY, Hong SP, Jang YH, Kim HO, Na CH, Lew BL, Ahn J, Park CO, Seo YJ, Lee YW, Son SW, Choi EH, Park YL, Roh JY. Lee JH, et al. Among authors: shin mk. Ann Dermatol. 2021 Dec;33(6):497-514. doi: 10.5021/ad.2021.33.6.497. Epub 2021 Nov 4. Ann Dermatol. 2021. PMID: 34858001 Free PMC article.
Assessment of Disease Severity and Quality of Life in Patients with Atopic Dermatitis from South Korea.
Son SW, Lee JH, Ahn J, Chang SE, Choi EH, Han TY, Jang YH, Kim HO, Kim MB, Kim YC, Ko HC, Ko JY, Lee SE, Lee YW, Lew BL, Na CH, Park CO, Park CW, Park KY, Park K, Park YL, Roh JY, Seo YJ, Shin MK, Lee S, Cho SH. Son SW, et al. Among authors: shin mk. Ann Dermatol. 2022 Dec;34(6):419-430. doi: 10.5021/ad.21.239. Ann Dermatol. 2022. PMID: 36478424 Free PMC article.
605 results